Cite
Dang AT, Levin-Epstein RG, Shabsovich D, et al. Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer. Adv Radiat Oncol. 2019;5(3):404-411doi: 10.1016/j.adro.2019.09.010.
Dang, A. T., Levin-Epstein, R. G., Shabsovich, D., Cao, M., King, C., Chu, F. I., Mantz, C. A., Stephans, K. L., Reddy, C. A., Loblaw, D. A., Cheung, P., Scorsetti, M., Cozzi, L., DeNittis, A. S., Wang, Y., Zaorsky, N., Nickols, N. G., Kupelian, P. A., Steinberg, M. L., & Kishan, A. U. (2020). Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer. Advances in radiation oncology, 5(3), 404-411. https://doi.org/10.1016/j.adro.2019.09.010
Dang, Audrey T, et al. "Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer." Advances in radiation oncology vol. 5,3 (2020): 404-411. doi: https://doi.org/10.1016/j.adro.2019.09.010
Dang AT, Levin-Epstein RG, Shabsovich D, Cao M, King C, Chu FI, Mantz CA, Stephans KL, Reddy CA, Loblaw DA, Cheung P, Scorsetti M, Cozzi L, DeNittis AS, Wang Y, Zaorsky N, Nickols NG, Kupelian PA, Steinberg ML, Kishan AU. Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer. Adv Radiat Oncol. 2019 Oct 14;5(3):404-411. doi: 10.1016/j.adro.2019.09.010. eCollection 2020. PMID: 32529134; PMCID: PMC7276661.
Copy
Download .nbib